Physician profile
Constance Faro
NPI 1306899612
$1,975.29
in general payments reported to CMS, 2019-2025
31 companies · $141 in 2025
The $141 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $203 · 2020: $250 · 2021: $289 · 2022: $827 · 2023: $265 · 2025: $141.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $305 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $305.31 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $315.26 | 2019-2022 | |
| Aspira Women'S Health INC | $198.84 | 2022 | |
| Astellas Pharma US INC | $182.08 | 2023-2025 | Veozah, Myrbetriq |
| Hologic Sales and Service, LLC | $167.99 | 2019-2023 | Coolseal Generator |
| Pfizer INC. | $148.25 | 2019-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $81.05 | 2021-2023 | |
| Exeltis, USA INC. | $76.92 | 2021-2023 | Tyblume |
| Coopersurgical, INC. | $71.23 | 2020-2025 | Paragard T 380a |
| Allergan, INC. | $69.99 | 2019-2020 | |
| Medtronic, INC. | $68.91 | 2022 | |
| Avion Pharmaceuticals | $65.71 | 2019-2021 | |
| Scynexis, INC. | $50.40 | 2022 | |
| Mayne Pharma Commercial LLC | $47.97 | 2022 | |
| Myovant Sciences INC. | $46.11 | 2022 | |
| Agile Therapeutics, INC. | $41.23 | 2021-2022 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dysis Medical, INC. | $35.13 | 2021 | |
| Lupin INC. | $33.02 | 2020-2021 | |
| Ethicon US, LLC | $29.71 | 2020-2021 | |
| Biogen, INC. | $27.08 | 2025 | Zurzuvae |
| Alexion Pharmaceuticals, INC. | $24.38 | 2022 | |
| Novo Nordisk INC | $24.24 | 2019-2020 | |
| Covidien Lp | $23.61 | 2019 | |
| Bolder Surgical, LLC | $20.09 | 2022 | |
| Organon LLC | $18.93 | 2022 | |
| Evofem Biosciences, INC. | $18.40 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $18.21 | 2020 | |
| Horizon Therapeutics Plc | $17.30 | 2019 | |
| Therapeuticsmd, INC. | $16.80 | 2019 | |
| Ascend Therapeutics US, LLC | $12.86 | 2020 | |
| Mylan Pharmaceuticals INC. | $12.55 | 2020 | |
| Minerva Surgical, INC | $11.04 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Constance Faro listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.